Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life

Andrew Y. Finlay, M. S. Salek, D Abeni, L. Tomás-Aragonés, O. D. van Cranenburgh, Andrea W M Evers, Gregor B E Jemec, D. Linder, L. Manolache, S. E. Marrón, C. A C Prinsen, P. Susitaival, P. V. Chernyshov, EADV Task Force on Quality of Life

Research output: Contribution to journalArticle

Abstract

The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.

Original languageEnglish
Pages (from-to)424-431
Number of pages8
JournalJournal of the European Academy of Dermatology and Venereology
Volume31
Issue number3
DOIs
Publication statusE-pub ahead of print - Sep 29 2016

Fingerprint

Expert Testimony
Advisory Committees
Dermatology
Quality of Life
Skin Diseases
Referral and Consultation
Communication
Psychology
Health

Keywords

  • Journal Article
  • Review

Cite this

Why quality of life measurement is important in dermatology clinical practice : An expert-based opinion statement by the EADV Task Force on Quality of Life. / Finlay, Andrew Y.; Salek, M. S.; Abeni, D; Tomás-Aragonés, L.; van Cranenburgh, O. D.; Evers, Andrea W M; Jemec, Gregor B E; Linder, D.; Manolache, L.; Marrón, S. E.; Prinsen, C. A C; Susitaival, P.; Chernyshov, P. V.; EADV Task Force on Quality of Life.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 31, No. 3, 29.09.2016, p. 424-431.

Research output: Contribution to journalArticle

Finlay, AY, Salek, MS, Abeni, D, Tomás-Aragonés, L, van Cranenburgh, OD, Evers, AWM, Jemec, GBE, Linder, D, Manolache, L, Marrón, SE, Prinsen, CAC, Susitaival, P, Chernyshov, PV & EADV Task Force on Quality of Life 2016, 'Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life', Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 3, pp. 424-431. https://doi.org/10.1111/jdv.13985
Finlay, Andrew Y. ; Salek, M. S. ; Abeni, D ; Tomás-Aragonés, L. ; van Cranenburgh, O. D. ; Evers, Andrea W M ; Jemec, Gregor B E ; Linder, D. ; Manolache, L. ; Marrón, S. E. ; Prinsen, C. A C ; Susitaival, P. ; Chernyshov, P. V. ; EADV Task Force on Quality of Life. / Why quality of life measurement is important in dermatology clinical practice : An expert-based opinion statement by the EADV Task Force on Quality of Life. In: Journal of the European Academy of Dermatology and Venereology. 2016 ; Vol. 31, No. 3. pp. 424-431.
@article{bee7acc83bf44f7d9c82f902d110a197,
title = "Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life",
abstract = "The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.",
keywords = "Journal Article, Review",
author = "Finlay, {Andrew Y.} and Salek, {M. S.} and D Abeni and L. Tom{\'a}s-Aragon{\'e}s and {van Cranenburgh}, {O. D.} and Evers, {Andrea W M} and Jemec, {Gregor B E} and D. Linder and L. Manolache and Marr{\'o}n, {S. E.} and Prinsen, {C. A C} and P. Susitaival and Chernyshov, {P. V.} and {EADV Task Force on Quality of Life}",
note = "{\circledC} 2016 European Academy of Dermatology and Venereology.",
year = "2016",
month = "9",
day = "29",
doi = "10.1111/jdv.13985",
language = "English",
volume = "31",
pages = "424--431",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - Why quality of life measurement is important in dermatology clinical practice

T2 - An expert-based opinion statement by the EADV Task Force on Quality of Life

AU - Finlay, Andrew Y.

AU - Salek, M. S.

AU - Abeni, D

AU - Tomás-Aragonés, L.

AU - van Cranenburgh, O. D.

AU - Evers, Andrea W M

AU - Jemec, Gregor B E

AU - Linder, D.

AU - Manolache, L.

AU - Marrón, S. E.

AU - Prinsen, C. A C

AU - Susitaival, P.

AU - Chernyshov, P. V.

AU - EADV Task Force on Quality of Life

N1 - © 2016 European Academy of Dermatology and Venereology.

PY - 2016/9/29

Y1 - 2016/9/29

N2 - The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.

AB - The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.

KW - Journal Article

KW - Review

U2 - 10.1111/jdv.13985

DO - 10.1111/jdv.13985

M3 - Article

C2 - 27684717

VL - 31

SP - 424

EP - 431

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 3

ER -